Table 3.
Construct (range) | Group | Baseline, Mean (95% CI) | 6 Weeks, Mean (95% CI) | 22 Weeks, Mean (95% CI) | 58 Weeks, Mean (95% CI) | Group, F (P) | Group × Time, F (P) | Time, F (P) |
---|---|---|---|---|---|---|---|---|
AT user primary outcome | ||||||||
SMAF ADL & Mobility (−39 - 0) | E | −8.8 -(10.3-7.3) | −8.6 -(10.1-7.1) | −9.0 -(10.5-7.5) | −10.5 -(12.0-9.0) | 1.90 (.171) | 1.81 (.146) | 4.19 (.007) |
C | −8.1 -(9.6-6.7) | −7.9 -(9.4-6.5) | −7.2 -(8.7-5.7) | −8.4 -(9.9-6.9) | ||||
Secondary outcomes | ||||||||
SMAF IADL (−24 - 0) | E | −11.6 -(12.9-10.3) | −11.7 -(13.0-10.4) | −12.2 -(13.6-10.9) | −12.8 -(14.1-11.4) | .054 (.817) | 4.66 (.004) | .140 (.936) |
C | −12.2 -(13.4-10.9) | −12.5 -(13.8-11.2) | −11.8 -(13.1-10.5) | −11.1 -(12.4-9.7) | ||||
SR-FIMU (13-91) | E | 74.4 (70.5-78.2) | 72.3 (68.5-76.2) | 72.5 (68.7-76.4) | 71.7 (67.8-75.6) | 1.77 (.187) | 1.86 (.137) | .830 (.479) |
C | 75.2 (71.5-78.9) | 75.8 (72.0-79.6) | 77.5 (73.6-81.3) | 75.7 (71.8-79.6) | ||||
SR-FIMCG (13-91) | E | 71.3 (67.5-75.2) | 70.2 (66.3-74.1) | 70.7 (66.8-74.6) | 69.7 (65.7-73.7) | 1.47 (.229) | 1.39 (.246) | 1.05 (.373) |
C | 72.1 (68.3-75.9) | 74.2 (70.4-78.1) | 75.1 (71.2-79.0) | 72.6 (68.6-76.6) | ||||
RNLI (0-110) | E | 75.1 (69.5-80.7) | 78.4 (72.7-84.2) | 76.3 (70.5-82.2) | 76.1 (70.2-82.1) | 1.35 (.249) | 1.98 (.118) | 2.81 (.040) |
C | 67.5 (61.9-73.0) | 71.9 (66.0-77.7) | 77.7 (71.8-83.5) | 73.7 (67.7-79.8) | ||||
Caregiver primary outcome | ||||||||
CATOM 1-14 (14-70) | E | 46.9 (43.6-50.1) | 48.8 (45.5-52.1) | 50.5 (47.2-53.8) | 50.0 (46.7-53.4) | 2.69 (.105) | .278 (.841) | 7.12 (.001) |
C | 49.8 (46.6-53.0) | 52.1 (48.8-55.3) | 53.3 (50.0-56.6) | 54.4 (51.1-57.8) | ||||
Secondary outcomes | ||||||||
CATOM 15-18 (4-20) | E | 14.5 (13.2-15.7) | 15.1 (13.8-16.4) | 15.6 (14.2-16.9) | 15.6 (14.3-17.0) | 1.35 (.249) | .275 (.844) | 4.48 (.004) |
C | 15.1 (13.8-16.3) | 16.4 (15.1-17.7) | 16.3 (14.9-17.6) | 16.7 (15.3-18.0) | ||||
CBI (0-56) | E | 20.5 (17.0-24.0) | 20.3 (16.8-23.8) | 19.6 (16.0-23.2) | 20.3 (16.7-24.0) | .894 (.347) | .652 (.582) | 1.38 (.250) |
C | 19.9 (16.4-23.3) | 18.1 (14.6-21.6) | 17.0 (13.4-20.6) | 17.3 (13.6-20.9) | ||||
EQ-5D descriptive items (5-15) | E | 6.6 (6.2-7.0) | 6.9 (6.5-7.4) | 6.8 (6.4-7.2) | 6.9 (6.5-7.4) | .873 (.353) | .829 (.479) | 1.25 (.293) |
C | 6.6 (6.2-7.0) | 6.5 (6.1-6.9) | 6.5 (6.1-6.9) | 6.7 (6.3-7.1) | ||||
EQ-5D perceived health (0-100) | E | 73.7 (69.0-78.3) | 75.1 (70.3-79.8) | 75.5 (70.7-80.3) | 75.1 (70.1-80.0) | 1.52 (.222) | .514 (.673) | .414 (.743) |
C | 78.9 (74.3-83.4) | 77.3 (72.6-82.0) | 79.8 (74.9-84.7) | 76.5 (71.5-81.5) |
Abbreviations: ADL Activities of daily living, IADL Instrumental activities of daily living, CATOM Caregiver Assistive Technology Outcome Measurement, CBI Caregiver Burden Inventory, EQ-5D European Quality of Life index, RNLI Reintegration to Normal Living Index, SMAF Functional Autonomy Measurement System, SR-FIMU/CG Self-Reported Functional Independence Measure (user/caregiver)
Bold numbers: significant time, group, or time X group interaction effects